Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas

Piunti, Andrea, Hashizume, Rintaro, Morgan, Marc A, Bartom, Elizabeth T, Horbinski, Craig M, Marshall, Stacy A, Rendleman, Emily J, Ma, Quanhong +9 more·2017·Nature Medicine

DOI 10.1038/nm.4296

Cited by (458)

Items 101–200 of 458

Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss
Dylan M. Marchione, Amanda Lisby, Angela Nicole Viaene, Mariarita Santi, MacLean Nasrallah, Liping Wang, Erik Abraham Williams, Ana Belén Larque, Ivan A. Chebib, Benjamin Aaron Garcia et al. · 2019 · Modern Pathology
Oncohistones: Exposing the nuances and vulnerabilities of epigenetic regulation
Michelle M. Mitchener, Tom W. Muir · 2022 · Molecular Cell
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas and MGMT Silencing to Temozolomide Sensitivity in IDH-Mutant Gliomas
Hideaki Abe, Manabu Natsumeda, Yu Kanemaru, Jun Watanabe, Yoshihiro Tsukamoto, Masayasu Okada, Junichi Yoshimura, Makoto Oishi, Yukihiko Fujii · 2018 · Neurologia medico-chirurgica
Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma
Nathan A. Dahl, Etienne P. Danis, Ilango Balakrishnan, Dong Wang, Angela M. Pierce, Faye M. Walker, Ahmed Gilani, Natalie Julie Serkova, Krishna P.C. Madhavan, Susan P. Fosmire et al. · 2020 · Cell Reports
Diffuse midline glioma: review of epigenetics
Tabitha M. Cooney, Evan Lubanszky, Rachna Prasad, Cynthia E Hawkins, Sabine Mueller · 2020 · Journal of Neuro-Oncology
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG
Anahid Ehteda, Sandy Simon, Laura Franshaw, Federico Manuel Giorgi, Jie Liu, Swapna Mahurkar Joshi, Jourdin R.C. Rouaen, Chi Nam Ignatius Pang, Ruby Pandher, Chelsea Mayoh et al. · 2021 · Cell Reports
EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma
Anne Jenseit, Aylin Camgöz, Stefan Michael Pfister, Marcel Kool · 2021 · Acta Neuropathologica
Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
Elisha Hayden, Holly Holliday, Rebecca J. Lehmann, Aaminah Khan, Maria Tsoli, Benjamin S. Rayner, David Simon Ziegler · 2021 · Cancers
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
Jin Qi, Darian R. Esfahani, T. Huang, Patrick A. Ozark, Elizabeth T. Bartom, Rintaro Hashizume, Erin R. Bonner, S. An, Craig Horbinski, Charles David James et al. · 2019 · Acta Neuropathologica Communications
PRC2 engages a bivalent H3K27M-H3K27me3 dinucleosome inhibitor
Katharine L. Diehl, Eva J. Ge, Daniel N. Weinberg, Krupa S. Jani, C. David Allis, Tom W. Muir · 2019 · Proceedings of the National Academy of Sciences
Monitoring protein communities and their responses to therapeutics
Hanna G. Budayeva, Donald S. Kirkpatrick · 2020 · Nature Reviews Drug Discovery
H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines
Andria Rakotomalala, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, Paul Huchedé, Audrey Hochart, Audrey Restouin, Rémy Castellano, Yves Collette et al. · 2021 · Cancers
An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields
Sven Beyes, Naiara G. Bediaga, Alessio Zippo · 2021 · Cancers
Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours
Alexandra Avgustinova, Aikaterini Symeonidi, Andrés Castellanos‐Martín, Uxue Urdiroz-Urricelqui, Llorenç Solé‐Boldo, Mercè Martı́n, Ivan Pérez-Rodríguez, Neus Prats, Ben Lehner, Fran Supek et al. · 2018 · Nature Cell Biology
CoBRA: Containerized Bioinformatics Workflow for Reproducible ChIP/ATAC-Seq Analysis
Xintao Qiu, Avery S. Feit, Ariel Feiglin, Yingtian Xie, Nikolas Kesten, Len Taing, Joseph Perkins, Shengqing Stan Gu, Yihao Li, Paloma Cejas et al. · 2021 · Genomics Proteomics & Bioinformatics
H3K27M mutant glioma: Disease definition and biological underpinnings
Amanda Muhs Saratsis, Truman Knowles, Antonela Petrović, Javad Nazarian · 2023 · Neuro-Oncology
H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features
Naohiro Makise, Masaya Sekimizu, Eiichi Konishi, Toru Motoi, Takashi Kubo, Hisashi Ikoma, Shun-ichi I. WATANABE, Tomotake Okuma, Nobuyoshi Hiraoka, Masashi Fukayama et al. · 2018 · Modern Pathology
hsa-miR-20a-5p attenuates allergic inflammation in HMC-1 cells by targeting HDAC4
Yi Chao Lu, Zhenjie Li, Baoqiang Xie, Yan Song, Xiaoqing Ye, Pingping Liu · 2019 · Molecular Immunology
Oncohistones: Hijacking the Histone Code
Varun Sahu, Chao Lü · 2022 · Annual Review of Cancer Biology
Loss of H3K27 Trimethylation Promotes Radiotherapy Resistance in Medulloblastoma and Induces an Actionable Vulnerability to BET Inhibition
Nishanth Gabriel, Kumaresh Balaji, Kay Jayachandran, Matthew J. Inkman, Jin Zhang, Sonika Dahiya, Michael Goldstein · 2022 · Cancer Research
Invited Review: Emerging functions of histone H3 mutations in paediatric diffuse high‐grade gliomas
L H Kasper, Suzanne J. Baker · 2019 · Neuropathology and Applied Neurobiology
H3 K27M-altered glioma and diffuse intrinsic pontine glioma: Semi-systematic review of treatment landscape and future directions
Martin J. van den Bent, Amanda Muhs Saratsis, Marjolein Geurts, Enrico Franceschi · 2023 · Neuro-Oncology
Diffuse intrinsic pontine glioma (DIPG): A review of current and emerging treatment strategies
Luke J. Weisbrod, Thiraviyam Anand, Raghupathy Vengoji, Nicole Shonka, Maneesh Jain, Winson S. Ho, Surinder K. Batra, Afshin Salehi · 2024 · Cancer Letters
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
Shiri Levy, Logeshwaran Somasundaram, Infencia Xavier Raj, Diego Ic-Mex, Ashish Phal, Sven Schmidt, Weng I. Ng, Daniel Mar, Justin A. Decarreau, Nicholas Moss et al. · 2022 · Cell Reports
Intranasal delivery of Borneol/R8dGR peptide modified PLGA nanoparticles co-loaded with curcumin and cisplatin alleviate hypoxia in pediatric brainstem glioma which improves the synergistic therapy
Xiao Guang Zhao, Shuting Ni, Yangjie Song, Kaili Hu · 2023 · Journal of Controlled Release
Proteins and Proteoforms: New Separation Challenges
Regnier, Fred E., Kim, JinHee · 2018 · Analytical Chemistry
Histone tail analysis reveals H3K36me2 and H4K16ac as epigenetic signatures of diffuse intrinsic pontine glioma
Shejuan An, Jeannie M. Camarillo, Tina Yi-Ting Huang, Daphne D. Li, Juliette A. Morris, Madeline Zoltek, Jin Qi, Mandana Behbahani, Madhuri Kambhampati, Neil L. Kelleher et al. · 2020 · Journal of Experimental & Clinical Cancer Research
A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
Swati Dhar, Samantha Gadd, Priyam A. Patel, Jake Vaynshteyn, G. Praveen Raju, Rintaro Hashizume, Daniel Jay Brat, Oren Josh Becher · 2022 · Acta Neuropathologica Communications
Histone mutations in cancer
Kimberly N. Espinoza Pereira, Jixiu Shan, Jonathan D. Licht, Richard Lynn Bennett · 2023 · Biochemical Society Transactions
Polycomb‐mediated gene regulation in human brain development and neurodevelopmental disorders
Nora Bölicke, Mareike Albert · 2022 · Developmental Neurobiology
Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma
Yu Sun, Ye Sun, Kun Huang Yan, Zhuxuan Li, Cheng Xu, Yibo Geng, Changcun Pan, Xin Chen, Liwei Zhang, Qiaoran Xi · 2019 · EBioMedicine
DNA methylation and histone variants in aging and cancer
Adèle Mangelinck, Carl Mann · 2021 · International review of cytology
Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
Matthew J Pun, Drew W. Pratt, Patricia R. Nano, Piyush K. Joshi, Li Jiang, Bernhard Englinger, Arvind U.K. Rao, Marcin P. Cieslik, Arul M. Chinnaiyan, Kenneth Aldape et al. · 2023 · Acta Neuropathologica Communications
Shared ACVR1 mutations in FOP and DIPG: Opportunities and challenges in extending biological and clinical implications across rare diseases
Harry J. Han, Payal Jain, Adam Cain Resnick · 2017 · Bone
Emerging Advances in Combinatorial Treatments of Epigenetically Altered Pediatric High-Grade H3K27M Gliomas
Katarzyna B. Leszczyńska, Chinchu Jayaprakash, Bozena Kaminska, Jakub Mieczkowski · 2021 · Frontiers in Genetics
Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
Aleeha Noon, Stefanie Galbán · 2023 · Neoplasia
Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity
Daniel J. Asby, Clare L. Killick-Cole, Lisa J. Boulter, William Singleton, Claire Asby, Marcella J. Wyatt, Neil U. Barua, Alison S. Bienemann, Steven Gill · 2018 · Cancer Management and Research
Genomic profiling and prognostic factors of H3 K27M ‐mutant spinal cord diffuse glioma
Ruichao Chai, Hao Yan, Song‐Yuan An, Bo Pang, Huiyuan Chen, Quanhua Mu, Kenan Zhang, Yao-Wu Zhang, Yu‐Qing Liu, Xing Liu et al. · 2023 · Brain Pathology
Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE
Andrew D.J. Pearson, Steven G. DuBois, Victoria Buenger et al. · 2021 · European Journal of Cancer
Altered pathways and targeted therapy in double hit lymphoma
Yuxin Zhuang, Jinxin Che, Meijuan Wu, Yu Lian Guo, Yongjin Xu, Xiaowu Dong, Haiyan Yang · 2022 · Journal of Hematology & Oncology
Characterizing the biology of primary brain tumors and their microenvironment via single-cell profiling methods
L. Nicolas Gonzalez Castro, Ilon Liu, Mariella G. Filbin · 2022 · Neuro-Oncology
Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeutics
Nicolina Jovanovich, Ahmed Habib, Jeffery R. Head, Farrukh Hameed, Sameer Agnihotri, Pascal Olivier Zinn · 2023 · Neuro-Oncology Advances
Polycomb-group proteins in the initiation and progression of cancer
Xiujuan Zhao, Xudong Wu · 2021 · Journal of genetics and genomics/Journal of Genetics and Genomics
Polycomb repressive complex 2 in the driver’s seat of childhood and young adult brain tumours
Brian Krug, Ashot S. Harutyunyan, Shriya Deshmukh, Nada Jabado · 2021 · Trends in Cell Biology
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
Dana Messinger, Micah K. Harris, Jessica R. Cummings, Chase Thomas, Tao Yang, Stefan R. Sweha, Rinette W.L. Woo, Robert Siddaway, Martin Burkert, Stefanie Stallard et al. · 2022 · Neuro-Oncology
Genetic Abnormalities, Clonal Evolution, and Cancer Stem Cells of Brain Tumors
Ugo Testa, Germana Castelli, Elvira Pelosi · 2018 · Medical Sciences
Histone Mutations in Cancer
Kosuke Funato, Viviane S. Tabar · 2017 · Annual Review of Cancer Biology
Mechanism of cancer: Oncohistones in action
Lei Qiu, Xiaoyan Hu, Qian Jing, Xinyi Zeng, Kui Ming Chan, Junhong Han · 2018 · Journal of genetics and genomics/Journal of Genetics and Genomics
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance
Liliana Montella, Mariella Cuomo, Nunzio Del Gaudio, Michela Buonaiuto, Davide Costabile, Roberta Visconti, Teodolinda Di Risi, Roberta Vinciguerra, Federica Trio, Sara Ferraro et al. · 2022 · International Journal of Cancer
JQ-1 Inhibits Colon Cancer Proliferation via Suppressing Wnt/β-Catenin Signaling and miR-21
Yan Zhang, Suli Tian, Jidong Xiong, Yongxu Zhou, Hongyu Song, Chang Liu · 2018 · Chemical Research in Toxicology
Prognostic role of H3K27M mutation, histone H3K27 methylation status, and EZH2 expression in diffuse spinal cord gliomas
Yukitomo Ishi, Soichiro Takamiya, Toshitaka Seki, Kazuyoshi Yamazaki, Kazutoshi Hida, Kanako C. Hatanaka, Yusuke Ishida, Yoshitaka Oda, Shinya Tanaka, Shigeru Yamaguchi · 2020 · Brain Tumor Pathology
The Epigenetics of Glioma Stem Cells: A Brief Overview
Luis Miguel Valor, Irati Hervás-Corpión · 2020 · Frontiers in Oncology
Therapeutic targeting of transcriptional elongation in diffuse intrinsic pontine glioma
Hiroaki Katagi, Nozomu Takata, Yuki Aoi, Yongzhan Zhang, Emily Jane Rendleman, Gavin T. Blyth, Frank Eckerdt, Yusuke Tomita, Takahiro Sasaki, Amanda Muhs Saratsis et al. · 2021 · Neuro-Oncology
Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells
Tina Huang, Andrea Piunti, Jin Qi, Marc A. Morgan, Elizabeth T. Bartom, Ali Shilatifard, Amanda Muhs Saratsis · 2020 · Acta Neuropathologica Communications
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors
Yukitomo Ishi, Yongzhan Zhang, Ali Zhang, Takahiro Sasaki, Andrea Piunti, Amreena Suri, Jun Watanabe, Kouki Abe, Xingyao He, Hiroaki Katagi et al. · 2022 · Molecular Cancer Therapeutics
Pediatric Diffuse Midline Glioma H3K27-Altered: From Developmental Origins to Therapeutic Challenges
Manuela Mandorino, Ahana Maitra, Domenico Armenise, Olga Maria Baldelli, Morena Miciaccia, Savina Ferorelli, Maria Grazia Perrone, Antonio Scilimati · 2024 · Cancers
microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma
Jian Lu, Hongming Ji, Huoquan Tang, Zhongye Xu · 2018 · Biochemical and Biophysical Research Communications
Inhibition of microglial EZH2 leads to anti-tumoral effects in pediatric diffuse midline gliomas
Lily Keane, Mathilde Cheray, Dalel Saidi, Caoimhe Kirby, Lara Frieß, Patricia González-Rodríguez, Maren Elisabeth Gerdes, Kathleen Grabert, Barry W. McColl, Bertrand Joseph · 2021 · Neuro-Oncology Advances
Histone H3.3 K27M chromatin functions implicate a network of neurodevelopmental factors including ASCL1 and NEUROD1 in DIPG
Nichole Lewis, Rachel Herndon Klein, Cailin Kelly, Jennifer Q. Yee, Paul S. Knoepfler · 2022 · Epigenetics & Chromatin
Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas
Mateus Mota, Stefan R. Sweha, Matthew J Pun, Siva Kumar Natarajan, Yujie Ding, Chan Chung, Debra Hawes, Fusheng Yang, Alexander Russell Judkins, Susanta Samajdar et al. · 2023 · Proceedings of the National Academy of Sciences
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition
Pierre Romero, Laia Richart, Setareh Aflaki, Ambre Petitalot, Megan Burton, Audrey Michaud, Julien Masliah‐Planchon, Frédérique Kuhnowski, Samuel Le Cam, Carlos Baliñas-Gavira et al. · 2024 · Nature Communications
Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma
Xu Zhang, Zhiguo Zhang · 2019 · Trends in cancer
Convection-Enhanced Delivery of Enhancer of Zeste Homolog-2 (EZH2) Inhibitor for the Treatment of Diffuse Intrinsic Pontine Glioma
Takahiro Sasaki, Hiroaki Katagi, Stewart Goldman, Oren Josh Becher, Rintaro Hashizume · 2020 · Neurosurgery
Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma
Jennifer Karin Ocasio, Kaitlin M. Budd, Jordan T. Roach, Jared M. Andrews, Suzanne J. Baker · 2023 · Cancer and Metastasis Reviews
H3.3K27M-induced chromatin changes drive ectopic replication through misregulation of the JNK pathway in C. elegans
Kamila Delaney, Maude Strobino, Joanna M. Wenda, Andrzej Pankowski, Florian A Steiner · 2019 · Nature Communications
Epigenetic reprogramming and chromatin accessibility in pediatric diffuse intrinsic pontine gliomas: a neural developmental disease
Flor Mendez, Felipe Javier Núñez, María Belén Garcia-Fabiani, Santiago Haase, Stephen V. Carney, Jessica C. Gauss, Oren Josh Becher, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2019 · Neuro-Oncology
Recent Advances in Pediatric Cancer Research
Troy A. McEachron, Lee J. Helman · 2021 · Cancer Research
Preclinical therapeutic targets in diffuse midline glioma
Michaël Hananja Meel, Gertjan J.L. Kaspers, Esther Hulleman · 2019 · Drug Resistance Updates
Chromatin-Remodeled State in Lymphoma
Yuxuan Liu, Yulissa Gonzalez, Jennifer Effie Amengual · 2019 · Current Hematologic Malignancy Reports
Radiosensitization in Pediatric High-Grade Glioma: Targets, Resistance and Developments
Dennis Serge Metselaar, Aimée du Chatinier, Iris Stuiver, Gertjan J.L. Kaspers, Esther Hulleman · 2021 · Frontiers in Oncology
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
S P Wang, Sandra Carolina Ordonez‐Rubiano, Alisha Dhiman, Guanming Jiao, Brayden P. Strohmier, Casey J. Krusemark, Emily C. Dykhuizen · 2021 · NAR Cancer
Superenhancers as master gene regulators and novel therapeutic targets in brain tumors
Hai-Hui Zhuang, Qiang Qu, Xin-Qi Teng, Ying-Huan Dai, Jian Qu · 2023 · Experimental & Molecular Medicine
CDK4/6 and PDGFRA Signaling as Therapeutic Targets in Diffuse Intrinsic Pontine Glioma
Christine M. Hoeman, Chen Shen, Oren Josh Becher · 2018 · Frontiers in Oncology
Identification of a small-molecule compound that inhibits homodimerization of oncogenic NAC1 protein and sensitizes cancer cells to anticancer agents
Xiaohui Wang, Cheng Ji, HongHan Zhang, Yu Shan, YiJie Ren, YanWei Hu, LiangRong Shi, LingChuan Guo, WeiDong Zhu, YuJuan Xia et al. · 2019 · Journal of Biological Chemistry
HiHiMap: single-cell quantitation of histones and histone posttranslational modifications across the cell cycle by high-throughput imaging
Linda K. Zane, Fleur Chapus, Gianluca Pegoraro, Tom Misteli · 2017 · Molecular Biology of the Cell
The growing role of epigenetics in childhood cancers
Eshini Panditharatna, Mariella G. Filbin · 2019 · Current Opinion in Pediatrics
H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes
Charles A. Day, Edward H. Hinchcliffe, James Robinson · 2022 · Cells
Brain‐Targeted Exosomes‐Based Drug Delivery System to Overcome the Treatment Bottleneck of Brainstem Glioma
Junge Chen, Shaobo Shan, Bozhang Xia, Liwei Zhang, Xing‐Jie Liang · 2023 · Advanced Functional Materials
Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas
Robert F. Koncar, Brittany Dey, Ann-Catherine J. Stanton, Nishant Agrawal, Michelle Wassell, Lauren H. McCarl, Abigail L. Locke, Lauren Sanders, Olena M. Vaske, Max I. Myers et al. · 2019 · Cancer Research
Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
Maya Srikanth Graham, Ingo K. Mellinghoff · 2020 · International Journal of Molecular Sciences
Gliomas in Children
Dominik Sturm, Mariella G. Filbin · 2018 · Seminars in Neurology
Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
John A. DeSisto, Patrick C. Flannery, Rakeb Lemma et al. · 2019 · Molecular Cancer Therapeutics
Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors
Yuhei Sangatsuda, Fumihito Miura, Hiromitsu Araki, Masahiro Mizoguchi, Nobuhiro Hata, Daisuke Kuga, Ryusuke Hatae, Yojiro Akagi, Takeo Amemiya, Yutaka Fujioka et al. · 2020 · Scientific Reports
Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors
Fan Chen, Aria L. Byrd, Jinpeng Liu, Robert M Flight, Tanner J. DuCote, Kassandra J. Naughton, Xiulong Song, Abigail R. Edgin, Alexsandr Lukyanchuk, Danielle T. Dixon et al. · 2023 · Nature Communications
Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Hsiao P. J. Voon, Linda L. Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison E. Morey, Toby D. M. Bell et al. · 2023 · Genome biology
CKAP2 Promotes Ovarian Cancer Proliferation and Tumorigenesis Through the FAK-ERK Pathway
Mei Zhang, Longjun Zhao · 2017 · DNA and Cell Biology
Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Cavan P. Bailey, Mary Figueroa, Sana Mohiuddin, Wafik Tharwat Zaky, Joya Chandra · 2018 · Bioengineering
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Deepak Kanojia, Wojciech K. Panek, Álex Cordero et al. · 2020 · Science Translational Medicine
BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma
Jun Watanabe, Matthew R. Clutter, Michael J. Gullette, Takahiro Sasaki, Eita Uchida, Savneet Kaur, Yan Mo, Kouki Abe, Yukitomo Ishi, Nozomu Takata et al. · 2024 · Journal of Clinical Investigation
Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier
Malik Johid Reza, Anthony T. Podany, Parvez Κhan, Christopher L. Shaffer, Jawed Akhtar Siddiqui, Janina Baranowska‐Kortylewicz, Jennifer Lê, Courtney Vail Fletcher, Sadia Afruz Ether, Sean N. Avedissian · 2023 · Cancer Medicine
Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities
Yusha Y. Sun, Cavan P. Bailey, Zsila Sousan Sadighi, Wafik Tharwat Zaky, Joya Chandra · 2020 · Journal of Neuro-Oncology
Glucose transporter Glut1 controls diffuse invasion phenotype with perineuronal satellitosis in diffuse glioma microenvironment
Masafumi Miyai, Tomohiro Kanayama, Fuminori Hyodo et al. · 2020 · Neuro-Oncology Advances
Pediatric Brain Tumors
Sonia Partap, Michelle Monje · 2020 · CONTINUUM Lifelong Learning in Neurology
Histone Variant H3.3 Mutations in Defining the Chromatin Function in Mammals
Matteo Trovato, Vibha Patil, Maja Gehre, Kyung‐Min Noh · 2020 · Cells
Alterations of Histone Modifications in Cancer
Amir Hosseini, Saverio Minucci · 2018 · Elsevier eBooks
Epigenetic Reprogramming of Host and Viral Genes by Human Cytomegalovirus Infection in Kasumi-3 Myeloid Progenitor Cells at Early Times Postinfection
Eleonora Forte, Fatma Ayaloglu Butun, Christian Marinaccio, Matthew John Schipma, Andrea Piunti, Mark W. Schroeder, Manoj Kandpal, Ali Shilatifard, Michael M. Abecassis, Mary Hummel · 2021 · Journal of Virology
The histone H3K9M mutation synergizes with H3K14 ubiquitylation to selectively sequester histone H3K9 methyltransferase Clr4 at heterochromatin
Chun‐Min Shan, Jin-Kwang Kim, Jiyong Wang, Kehan Bao, Yadong Sun, Huijie Chen, Jia‐Xing Yue, Alessandro Stirpe, Zhiguo Zhang, Chao Lü et al. · 2021 · Cell Reports
CDC20-Mediated hnRNPU Ubiquitination Regulates Chromatin Condensation and Anti-Cancer Drug Response
Cindy Wavelet-Vermuse, Olena Odnokoz, Yifan Xue, Xinghua Lu, Massimo Cristofanilli, Yong Wan · 2022 · Cancers
Epigenetic and Metabolic Changes in Diffuse Intrinsic Pontine Glioma
Jiyoon Park, Chan Chung · 2023 · Brain Tumor Research and Treatment
Fimepinostat Impairs NFκB and PI3K/AKT Signaling and Enhances Gemcitabine Efficacy in H3.3K27M-Diffuse Intrinsic Pontine Glioma
Dan Wang, Kun Huang Yan, Hongxing Yu, Haocheng Li, Wei Zhou, Yaqiang Hong, Shuning Guo, Yi Wang, Cheng Xu, Changcun Pan et al. · 2023 · Cancer Research